Randomized phase II study of pemetrexed and cisplatin as either induction or adjuvant chemotherapy in stage IB-II non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2015
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 26 Jul 2012 Actual end date (July 2008) added as reported by ClinicalTrials.gov.
- 31 Aug 2009 Status changed from active, no longer recruiting to discontinued.
- 01 Aug 2009 Results have been presented at the 13th World Conference on Lung Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History